|

RO7656594 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GDC-2992

Pipeline

Phase 1: 1

Top Sponsors

  • Genentech, Inc.1

Indications

  • Advanced Prostate Cancer1
  • Metastatic Prostate Cancer1
  • Cancer1

Scottsdale, Arizona1 trial

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

HonorHealth

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.